| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.092 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.085 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |